Breaking News
Noncultured epidermal suspension transplantation promising for the treatment of pediatric stable vitiligo
Noncultured epidermal suspension transplantation promising for the treatment of pediatric stable vitiligo
A new study has examined the efficacy and safety of autologous noncultured epidermal suspension transplantation for the treatment of stable pediatric vitiligo in 13 patients (aged 8-17 years). The patients had a total of 19 lesions with stable vitiligo. At the end of 1 year, 15 out of 19 lesions (79%) had > 90% repigmentation while the remaining 4 lesions had 75-90% repigmentation. Outcomes were independent of age, gender, site or size of lesion, type or duration of vitiligo. The majority of color matches (84.2%) were excellent at the final visit. No major adverse events were seen (Sahni, K. et al Clin Exptl Dermatol 2011, 36: 607).
Last updated: Saturday, December 17, 2011
AccessDermatology | © Copyright 2011 Prous Science S.A.U. a Thomson Reuters business or its licensors.
All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202
This website is optimized for Explorer 7.0 and above, Firefox 3.0, Safari, and Chrome. Content remains viewable in older versions, but loss of formatting and design elements may occur.
This site complies with the HONcode standard for trustworthy health information:
verify here.